Illumina Company Profile (NASDAQ:ILMN)

About Illumina

Illumina logoIllumina, Inc. (Illumina) offers sequencing and array-based solutions for genetic analysis. The Company's products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. The Company's customers include genomic research centers, academic institutions, government laboratories and hospitals, as well as pharmaceutical, biotechnology, agrigenomics and commercial molecular diagnostic laboratories, and consumer genomics companies. It provides sample-to-answer solutions to its customers in various areas of translational and clinical genomics, such as reproductive and genetic health, and oncology. It provides reproductive-health solutions, including preimplantation genetic screening and diagnosis, noninvasive prenatal testing, and neonatal and genetic health testing. It also provides whole-genome sequencing, genotyping and NIPT services. It has operations in the United States, Europe, Asia-Pacific and other markets.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: ILMN
  • CUSIP: 45232710
Key Metrics:
  • Previous Close: $163.37
  • 50 Day Moving Average: $157.27
  • 200 Day Moving Average: $153.40
  • 52-Week Range: $119.37 - $186.88
  • Trailing P/E Ratio: 53.21
  • Foreward P/E Ratio: 37.80
  • P/E Growth: 3.92
  • Market Cap: $23.90B
  • Outstanding Shares: 146,300,000
  • Beta: 0.79
Profitability:
  • Net Margins: 19.31%
  • Return on Equity: 22.89%
  • Return on Assets: 12.37%
Debt:
  • Debt-to-Equity Ratio: 0.46%
  • Current Ratio: 3.29%
  • Quick Ratio: 2.86%
Additional Links:
Companies Related to Illumina:

Analyst Ratings

Consensus Ratings for Illumina (NASDAQ:ILMN) (?)
Ratings Breakdown: 3 Sell Ratings, 12 Hold Ratings, 8 Buy Ratings
Consensus Rating:Hold (Score: 2.22)
Consensus Price Target: $150.80 (7.00% downside)

Analysts' Ratings History for Illumina (NASDAQ:ILMN)
Show:
DateFirmActionRatingPrice TargetDetails
2/21/2017Canaccord GenuityReiterated RatingHold$150.00View Rating Details
2/9/2017Leerink SwannBoost Price TargetMarket Perform$134.00 -> $138.00View Rating Details
2/1/2017Cantor FitzgeraldReiterated RatingNeutral$155.00View Rating Details
1/18/2017Deutsche Bank AGReiterated RatingHold$160.00View Rating Details
1/12/2017Robert W. BairdReiterated RatingNeutral$147.00 -> $153.00View Rating Details
1/11/2017Cowen and CompanyReiterated RatingOutperform$150.00View Rating Details
1/10/2017Evercore ISIReiterated RatingHold$139.00View Rating Details
1/10/2017Bank of America CorpUpgradeNeutral -> Buy$145.00 -> $175.00View Rating Details
1/9/2017Barclays PLCReiterated RatingEqual Weight$145.00View Rating Details
1/6/2017Janney Montgomery ScottReiterated RatingNeutral -> Sell$125.00View Rating Details
1/6/2017CL KingUpgradeNeutral -> BuyView Rating Details
12/7/2016Morgan StanleyLower Price TargetUnderweight$115.00 -> $100.00View Rating Details
11/3/2016BTIG ResearchReiterated RatingHoldView Rating Details
11/2/2016First AnalysisDowngradeEqual Weight -> Underweight$130.00 -> $116.00View Rating Details
10/14/2016ArgusReiterated RatingBuy$205.00 -> $170.00View Rating Details
10/12/2016Wells Fargo & CompanyReiterated RatingMarket Perform$150.00 -> $137.50View Rating Details
10/11/2016Citigroup Inc.DowngradeBuy -> Neutral$190.00 -> $140.00View Rating Details
7/27/2016J P Morgan Chase & CoBoost Price TargetOverweight$185.00 -> $200.00View Rating Details
7/27/2016MizuhoBoost Price TargetNeutral$138.00 -> $148.00View Rating Details
7/15/2016Piper Jaffray CompaniesReiterated RatingOverweight$161.00View Rating Details
5/4/2016Stifel NicolausReiterated RatingBuy$215.00 -> $160.00View Rating Details
5/3/2016NomuraLower Price TargetBuy$210.00 -> $180.00View Rating Details
4/22/2016Avondale PartnersReiterated RatingMarket Perform$175.00 -> $160.00View Rating Details
3/23/2016Goldman Sachs Group, Inc. (The)Lower Price Target$141.00View Rating Details
10/21/2015WedbushBoost Price TargetOutperform$150.00 -> $160.00View Rating Details
10/8/2015William BlairReiterated RatingBuyView Rating Details
4/23/2015Tigress FinancialUpgradeBuy -> Strong-Buy$421.00 -> $539.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Illumina (NASDAQ:ILMN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2017        
1/31/2017Q416$0.82$0.85$612.50 million$619.00 millionViewListenView Earnings Details
11/1/2016Q316$0.87$0.97$628.06 million$607.00 millionViewListenView Earnings Details
7/26/2016Q2$0.73$0.86$31.91 million$600.00 millionViewListenView Earnings Details
5/3/2016Q1$0.74$0.71$596.33 million$572.00 millionViewListenView Earnings Details
2/2/2016Q415$0.82$0.70$576.39 million$591.50 millionViewListenView Earnings Details
10/20/2015Q315$0.79$0.80$568.60 million$550.00 millionViewListenView Earnings Details
7/21/2015Q215$0.77$0.80$541.05 million$539.00 millionViewListenView Earnings Details
4/21/2015Q115$0.72$0.91$524.35 million$539.00 millionViewListenView Earnings Details
1/27/2015Q414$0.77$0.87$503.83 million$512.00 millionViewListenView Earnings Details
10/20/2014Q314$0.56$0.77$451.20 million$481.00 millionViewListenView Earnings Details
7/23/2014Q214$0.50$0.57$426.50 million$448.00 millionViewListenView Earnings Details
4/22/2014Q114$0.45$0.46$391.50 million$421.00 millionViewListenView Earnings Details
1/28/2014Q413$0.44$0.45$382.06 million$387.00 millionViewListenView Earnings Details
10/21/2013Q313$0.40$0.45$343.42 million$357.00 millionViewListenView Earnings Details
7/23/2013Q2 2013$0.40$0.43$331.77 million$346.09 millionViewListenView Earnings Details
4/22/2013Q1 2013$0.39$0.46$310.64 million$330.96 millionViewListenView Earnings Details
1/28/2013Q4 2012$0.41$0.42$303.13 million$309.30 millionViewListenView Earnings Details
10/23/2012$0.39$0.41ViewN/AView Earnings Details
7/24/2012$0.36$0.40ViewN/AView Earnings Details
4/23/2012$0.32$0.36ViewN/AView Earnings Details
2/7/2012$0.30$0.35ViewN/AView Earnings Details
10/25/2011$0.23$0.22ViewN/AView Earnings Details
4/26/2011$0.31$0.35ViewN/AView Earnings Details
2/8/2011$0.29$0.29ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Illumina (NASDAQ:ILMN)
Current Year EPS Consensus Estimate: $3.63 EPS
Next Year EPS Consensus Estimate: $4.29 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20167$0.67$0.86$0.77
Q2 20167$0.72$0.91$0.84
Q3 20165$0.88$0.93$0.91
Q4 20163$0.78$0.82$0.81
Q1 20173$0.63$0.82$0.69
Q2 20173$0.85$0.94$0.91
Q3 20173$0.95$1.03$1.00
Q4 20173$1.03$1.06$1.04
Q1 20181$0.99$0.99$0.99
Q2 20181$1.03$1.03$1.03
Q3 20181$1.10$1.10$1.10
Q4 20181$1.14$1.14$1.14
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Illumina (NASDAQ:ILMN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Illumina (NASDAQ:ILMN)
Insider Ownership Percentage: 1.60%
Institutional Ownership Percentage: 92.79%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/17/2017Daniel BradburyDirectorSell600$162.80$97,680.00View SEC Filing  
2/13/2017Omead OstadanEVPSell2,173$163.10$354,416.30View SEC Filing  
2/8/2017A Blaine BowmanDirectorSell3,000$162.74$488,220.00View SEC Filing  
2/6/2017Charles DadswellSVPSell572$161.26$92,240.72View SEC Filing  
1/30/2017Omead OstadanEVPSell259$160.90$41,673.10View SEC Filing  
1/19/2017Omead OstadanEVPSell2,378$160.06$380,622.68View SEC Filing  
1/11/2017A Blaine BowmanDirectorSell3,000$162.89$488,670.00View SEC Filing  
1/10/2017Charles DadswellSVPSell116$161.60$18,745.60View SEC Filing  
1/4/2017Daniel BradburyDirectorSell600$135.01$81,006.00View SEC Filing  
12/15/2016Omead OstadanEVPSell2,000$126.16$252,320.00View SEC Filing  
12/12/2016Daniel BradburyDirectorSell600$123.42$74,052.00View SEC Filing  
12/8/2016Omead OstadanEVPSell3,000$121.63$364,890.00View SEC Filing  
12/1/2016Omead OstadanEVPSell3,000$133.30$399,900.00View SEC Filing  
11/14/2016Daniel BradburyDirectorSell600$136.34$81,804.00View SEC Filing  
10/7/2016Daniel BradburyDirectorSell600$184.36$110,616.00View SEC Filing  
10/4/2016Charles DadswellSVPSell116$182.38$21,156.08View SEC Filing  
9/20/2016Robert S EpsteinDirectorSell300$174.29$52,287.00View SEC Filing  
9/15/2016Marc StapleyEVPSell1,270$172.87$219,544.90View SEC Filing  
9/14/2016Daniel BradburyDirectorSell600$171.25$102,750.00View SEC Filing  
8/23/2016Jay T FlatleyDirectorSell20,000$172.99$3,459,800.00View SEC Filing  
8/22/2016Robert S EpsteinDirectorSell300$170.27$51,081.00View SEC Filing  
8/17/2016Daniel BradburyDirectorSell600$168.42$101,052.00View SEC Filing  
8/15/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00View SEC Filing  
8/12/2016Roy A WhitfieldDirectorSell4,000$167.22$668,880.00View SEC Filing  
8/9/2016Jay T FlatleyDirectorSell10,000$165.97$1,659,700.00View SEC Filing  
8/1/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00View SEC Filing  
7/27/2016Charles DadswellSVPSell8,632$155.00$1,337,960.00View SEC Filing  
7/26/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00View SEC Filing  
7/20/2016Robert S EpsteinDirectorSell1,200$150.00$180,000.00View SEC Filing  
7/18/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00View SEC Filing  
7/14/2016A Blaine BowmanDirectorSell5,000$147.14$735,700.00View SEC Filing  
7/11/2016Christian O HenryEVPSell716$141.89$101,593.24View SEC Filing  
6/16/2016A Blaine BowmanDirectorSell5,000$135.08$675,400.00View SEC Filing  
6/15/2016Christian O HenryEVPSell2,141$137.90$295,243.90View SEC Filing  
6/13/2016Roy A WhitfieldDirectorSell3,800$140.44$533,672.00View SEC Filing  
6/1/2016Karin EasthamDirectorSell5,000$145.35$726,750.00View SEC Filing  
5/25/2016Christian O HenryEVPSell2,141$144.73$309,866.93View SEC Filing  
5/17/2016Christian O HenryEVPSell2,141$140.84$301,538.44View SEC Filing  
5/12/2016A Blaine BowmanDirectorSell5,000$137.11$685,550.00View SEC Filing  
4/27/2016Christian O HenryEVPSell2,141$138.46$296,442.86View SEC Filing  
4/18/2016Christian O HenryEVPSell2,141$176.01$376,837.41View SEC Filing  
4/18/2016Paul L BianchiVPSell1,884$175.00$329,700.00View SEC Filing  
4/14/2016A Blaine BowmanDirectorSell5,000$172.94$864,700.00View SEC Filing  
4/13/2016Christian O HenryEVPSell12,500$175.00$2,187,500.00View SEC Filing  
4/13/2016Paul L BianchiVPSell6,681$175.00$1,169,175.00View SEC Filing  
4/12/2016Jay T FlatleyCEOSell20,000$170.05$3,401,000.00View SEC Filing  
4/12/2016Roy A WhitfieldDirectorSell4,000$170.00$680,000.00View SEC Filing  
4/7/2016David R WaltDirectorSell4,000$168.90$675,600.00View SEC Filing  
4/5/2016Christian O HenryEVPSell2,141$166.07$355,555.87View SEC Filing  
4/4/2016Charles DadswellSVPSell8,382$167.81$1,406,583.42View SEC Filing  
3/23/2016Christian O HenryEVPSell2,141$155.05$331,962.05View SEC Filing  
3/22/2016Jay T FlatleyCEOSell10,000$154.18$1,541,800.00View SEC Filing  
3/21/2016Daniel BradburyDirectorSell1,200$155.63$186,756.00View SEC Filing  
3/21/2016Nicholas NaclerioSVPSell4,520$154.25$697,210.00View SEC Filing  
3/17/2016A Blaine BowmanDirectorSell5,000$145.24$726,200.00View SEC Filing  
3/15/2016David R WaltDirectorSell4,000$149.99$599,960.00View SEC Filing  
3/14/2016Christian O HenryEVPSell5,892$155.91$918,621.72View SEC Filing  
3/8/2016Charles DadswellSVPSell8,382$155.63$1,304,490.66View SEC Filing  
3/8/2016Jay T FlatleyCEOSell10,000$154.49$1,544,900.00View SEC Filing  
3/8/2016Omead OstadanEVPSell4,516$156.09$704,902.44View SEC Filing  
3/7/2016Charles DadswellSVPSell116$155.00$17,980.00View SEC Filing  
2/23/2016Jay T FlatleyCEOSell10,000$152.49$1,524,900.00View SEC Filing  
2/17/2016Daniel BradburyDirectorSell1,700$154.74$263,058.00View SEC Filing  
2/12/2016Roy A. WhitfieldDirectorSell3,750$140.30$526,125.00View SEC Filing  
2/1/2016Omead OstadanEVPSell1,108$156.73$173,656.84View SEC Filing  
1/26/2016Jay T. FlatleyCEOSell20,000$171.70$3,434,000.00View SEC Filing  
1/13/2016Jay T. FlatleyCEOSell20,000$168.81$3,376,200.00View SEC Filing  
1/4/2016Daniel BradburyDirectorSell1,700$182.80$310,760.00View SEC Filing  
12/28/2015Charles DadswellSVPSell168$188.63$31,689.84View SEC Filing  
12/22/2015Jay T. FlatleyCEOSell25,000$185.38$4,634,500.00View SEC Filing  
12/14/2015Roy A. WhitfieldDirectorSell3,750$175.07$656,512.50View SEC Filing  
12/11/2015Omead OstadanEVPSell260$179.90$46,774.00View SEC Filing  
12/11/2015Paul L BianchiVPSell197$179.90$35,440.30View SEC Filing  
12/10/2015Daniel BradburyDirectorSell1,700$182.37$310,029.00View SEC Filing  
12/8/2015Jay T. FlatleyCEOSell25,000$177.11$4,427,750.00View SEC Filing  
11/27/2015Robert S EpsteinDirectorSell1,000$185.56$185,560.00View SEC Filing  
11/25/2015Jay T. FlatleyCEOSell5,000$180.00$900,000.00View SEC Filing  
11/24/2015Jay T. FlatleyCEOSell20,000$173.27$3,465,400.00View SEC Filing  
11/16/2015Jay T. FlatleyCEOSell10,000$170.00$1,700,000.00View SEC Filing  
11/10/2015Daniel BradburyDirectorSell1,700$154.03$261,851.00View SEC Filing  
11/10/2015Jay T. FlatleyCEOSell10,000$154.58$1,545,800.00View SEC Filing  
11/3/2015Charles DadswellSVPSell158$150.00$23,700.00View SEC Filing  
10/15/2015Jay T. FlatleyCEOSell10,000$150.00$1,500,000.00View SEC Filing  
10/7/2015Daniel BradburyDirectorSell1,700$145.81$247,877.00View SEC Filing  
9/29/2015David R WaltDirectorSell2,000$171.65$343,300.00View SEC Filing  
9/22/2015Jay T. FlatleyCEOSell25,000$192.79$4,819,750.00View SEC Filing  
9/15/2015David R WaltDirectorSell2,000$206.45$412,900.00View SEC Filing  
9/14/2015Daniel BradburyDirectorSell1,700$203.89$346,613.00View SEC Filing  
9/9/2015Paul L. BianchiVPSell1,245$199.32$248,153.40View SEC Filing  
9/8/2015Jay T. FlatleyCEOSell25,000$194.87$4,871,750.00View SEC Filing  
9/8/2015Karin EasthamDirectorSell4,300$195.76$841,768.00View SEC Filing  
9/4/2015Roy A. WhitfieldDirectorSell4,500$192.63$866,835.00View SEC Filing  
9/1/2015David R WaltDirectorSell2,000$195.08$390,160.00View SEC Filing  
8/27/2015Jay T. FlatleyCEOSell25,000$200.16$5,004,000.00View SEC Filing  
8/18/2015David R WaltDirectorSell2,000$206.89$413,780.00View SEC Filing  
8/17/2015Daniel BradburyDirectorSell1,700$208.14$353,838.00View SEC Filing  
8/13/2015Jay T FlatleyCEOSell25,000$207.85$5,196,250.00View SEC Filing  
8/5/2015Roy A. WhitfieldDirectorSell4,500$215.22$968,490.00View SEC Filing  
7/24/2015A Blaine BowmanDirectorSell3,000$221.47$664,410.00View SEC Filing  
7/23/2015Jay T FlatleyCEOSell25,000$214.87$5,371,750.00View SEC Filing  
7/21/2015David R WaltDirectorSell12,000$235.24$2,822,880.00View SEC Filing  
7/17/2015Mostafa RonaghiSVPSell1,200$235.00$282,000.00View SEC Filing  
7/16/2015Christian O HenrySVPSell5,390$229.61$1,237,597.90View SEC Filing  
7/15/2015Mostafa RonaghiSVPSell3,000$227.19$681,570.00View SEC Filing  
7/14/2015David R WaltDirectorSell10,000$227.39$2,273,900.00View SEC Filing  
7/13/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
7/13/2015Michel BouchardCAOSell1,400$222.75$311,850.00View SEC Filing  
7/10/2015Omead OstadanSVPSell1,110$219.81$243,989.10View SEC Filing  
7/10/2015Robert S EpsteinDirectorSell2,000$219.81$439,620.00View SEC Filing  
7/9/2015Jay T FlatleyCEOSell25,000$218.10$5,452,500.00View SEC Filing  
7/7/2015David R WaltDirectorSell10,000$220.22$2,202,200.00View SEC Filing  
7/6/2015Daniel BradburyDirectorSell1,700$219.70$373,490.00View SEC Filing  
6/30/2015David R WaltDirectorSell10,000$217.64$2,176,400.00View SEC Filing  
6/25/2015Jay T FlatleyCEOSell25,000$220.34$5,508,500.00View SEC Filing  
6/24/2015A Blaine BowmanDirectorSell3,000$221.43$664,290.00View SEC Filing  
6/24/2015Christian O HenrySVPSell5,084$221.07$1,123,919.88View SEC Filing  
6/23/2015David R WaltDirectorSell12,000$220.11$2,641,320.00View SEC Filing  
6/17/2015Christian O HenrySVPSell3,751$215.71$809,128.21View SEC Filing  
6/16/2015David R WaltDirectorSell10,000$215.14$2,151,400.00View SEC Filing  
6/15/2015Nicholas NaclerioSVPSell6,590$214.33$1,412,434.70View SEC Filing  
6/15/2015Paul L BianchiVPSell3,408$215.83$735,548.64View SEC Filing  
6/12/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
6/12/2015Michel BouchardCAOSell1,400$216.11$302,554.00View SEC Filing  
6/11/2015Jay T FlatleyCEOSell25,000$216.41$5,410,250.00View SEC Filing  
6/10/2015Christian O HenrySVPSell10,000$214.94$2,149,400.00View SEC Filing  
6/10/2015Robert S EpsteinDirectorSell2,000$214.24$428,480.00View SEC Filing  
6/5/2015Roy A WhitfieldDirectorSell4,500$207.49$933,705.00View SEC Filing  
6/2/2015David R WaltDirectorSell10,000$204.42$2,044,200.00View SEC Filing  
6/1/2015Karin EasthamDirectorSell5,000$205.24$1,026,200.00View SEC Filing  
5/29/2015Daniel BradburyDirectorSell1,700$206.62$351,254.00View SEC Filing  
5/28/2015Jay T FlatleyCEOSell25,000$208.78$5,219,500.00View SEC Filing  
5/22/2015A Blaine BowmanDirectorSell3,000$204.58$613,740.00View SEC Filing  
5/19/2015David R WaltDirectorSell10,000$202.00$2,020,000.00View SEC Filing  
5/14/2015Christian O HenrySVPSell3,751$198.52$744,648.52View SEC Filing  
5/14/2015Jay T FlatleyCEOSell25,000$197.76$4,944,000.00View SEC Filing  
5/13/2015Paul L BianchiVPSell3,356$197.14$661,601.84View SEC Filing  
5/11/2015Robert S EpsteinDirectorSell2,000$196.49$392,980.00View SEC Filing  
4/28/2015David R WaltDirectorSell7,000$183.88$1,287,160.00View SEC Filing  
4/24/2015A Blaine BowmanDirectorSell3,000$190.73$572,190.00View SEC Filing  
4/23/2015Jay T FlatleyCEOSell25,000$189.57$4,739,250.00View SEC Filing  
4/21/2015David R WaltDirectorSell10,000$197.95$1,979,500.00View SEC Filing  
4/15/2015Christian O HenrySVPSell3,751$189.02$709,014.02View SEC Filing  
4/14/2015David R WaltDirectorSell7,000$188.23$1,317,610.00View SEC Filing  
4/13/2015Marc StapleyCFOSell3,000$190.12$570,360.00View SEC Filing  
4/13/2015Michel BouchardCAOSell1,400$188.61$264,054.00View SEC Filing  
4/13/2015Paul L BianchiVPSell3,390$187.22$634,675.80View SEC Filing  
4/10/2015Robert S EpsteinDirectorSell2,000$186.99$373,980.00View SEC Filing  
4/9/2015Jay T FlatleyCEOSell25,000$184.55$4,613,750.00View SEC Filing  
4/8/2015Daniel BradburyDirectorSell1,700$185.32$315,044.00View SEC Filing  
4/7/2015David R WaltDirectorSell5,000$184.28$921,400.00View SEC Filing  
4/6/2015Roy A WhitfieldDirectorSell4,600$181.32$834,072.00View SEC Filing  
3/26/2015Jay T FlatleyCEOSell25,000$181.34$4,533,500.00View SEC Filing  
3/24/2015David R WaltDirectorSell5,000$192.16$960,800.00View SEC Filing  
3/17/2015A Blaine BowmanDirectorSell3,000$192.30$576,900.00View SEC Filing  
3/16/2015Gerald MoellerDirectorSell2,700$193.36$522,072.00View SEC Filing  
3/16/2015Nicholas NaclerioSVPSell6,590$193.94$1,278,064.60View SEC Filing  
3/13/2015Paul L BianchiVPSell3,390$186.67$632,811.30View SEC Filing  
3/12/2015Marc StapleyCFOSell3,314$189.01$626,379.14View SEC Filing  
3/10/2015Richard KlausnerSVPSell1,186$191.75$227,415.50View SEC Filing  
3/10/2015Robert S EpsteinDirectorSell3,000$191.75$575,250.00View SEC Filing  
2/26/2015Jay T FlatleyCEOSell25,000$195.73$4,893,250.00View SEC Filing  
2/12/2015Jay T FlatleyCEOSell25,000$194.64$4,866,000.00View SEC Filing  
2/3/2015David R WaltDirectorSell7,000$190.89$1,336,230.00View SEC Filing  
2/2/2015Karin EasthamDirectorSell10,000$192.77$1,927,700.00View SEC Filing  
2/2/2015Nicholas NaclerioSVPSell15,250$194.37$2,964,142.50View SEC Filing  
1/27/2015Charles DadswellSVPSell224$198.90$44,553.60View SEC Filing  
1/27/2015David R WaltDirectorSell4,000$201.76$807,040.00View SEC Filing  
1/22/2015Jay T FlatleyCEOSell25,000$188.48$4,712,000.00View SEC Filing  
1/20/2015William H RastetterDirectorSell16,000$188.99$3,023,840.00View SEC Filing  
1/15/2015Marc StapleyCFOSell1,422$181.62$258,263.64View SEC Filing  
1/8/2015Jay T FlatleyCEOSell25,000$197.62$4,940,500.00View SEC Filing  
1/6/2015David R WaltDirectorSell6,000$188.55$1,131,300.00View SEC Filing  
1/2/2015Karin EasthamDirectorSell10,000$185.63$1,856,300.00View SEC Filing  
12/30/2014David R WaltDirectorSell5,000$186.95$934,750.00View SEC Filing  
12/29/2014Gerald MoellerDirectorSell8,000$187.05$1,496,400.00View SEC Filing  
12/26/2014Jay T FlatleyCEOSell25,000$186.71$4,667,750.00View SEC Filing  
12/23/2014David R WaltDirectorSell7,000$184.55$1,291,850.00View SEC Filing  
12/16/2014David R WaltDirectorSell5,000$178.35$891,750.00View SEC Filing  
12/15/2014Marc StapleyCFOSell1,422$181.09$257,509.98View SEC Filing  
12/11/2014Jay T FlatleyCEOSell25,000$185.79$4,644,750.00View SEC Filing  
12/9/2014David R WaltDirectorSell7,000$186.75$1,307,250.00View SEC Filing  
12/8/2014Daniel BradburyDirectorSell1,600$190.14$304,224.00View SEC Filing  
12/4/2014Karin EasthamDirectorSell10,000$191.87$1,918,700.00View SEC Filing  
12/1/2014Mostafa RonaghiSVPSell10,000$188.46$1,884,600.00View SEC Filing  
11/26/2014Paul L BianchiSVPSell1,626$189.20$307,639.20View SEC Filing  
11/17/2014Roy A WhitfieldDirectorSell4,000$178.26$713,040.00View SEC Filing  
11/14/2014Marc StapleyCFOSell1,422$181.13$257,566.86View SEC Filing  
11/13/2014Daniel BradburyDirectorSell2,100$186.88$392,448.00View SEC Filing  
11/13/2014Jay T FlatleyCEOSell25,000$189.32$4,733,000.00View SEC Filing  
11/3/2014Michel BouchardCAOSell631$195.68$123,474.08View SEC Filing  
11/3/2014Mostafa RonaghiSVPSell10,000$195.66$1,956,600.00View SEC Filing  
10/30/2014Daniel BradburyDirectorSell2,100$191.83$402,843.00View SEC Filing  
10/23/2014Jay T FlatleyCEOSell25,000$189.54$4,738,500.00View SEC Filing  
10/13/2014Daniel BradburyDirectorSell2,100$152.03$319,263.00View SEC Filing  
10/9/2014Jay T FlatleyCEOSell25,000$163.49$4,087,250.00View SEC Filing  
10/7/2014A Blaine BowmanDirectorSell4,456$159.51$710,776.56View SEC Filing  
10/1/2014Daniel BradburyDirectorSell2,100$158.88$333,648.00View SEC Filing  
10/1/2014Mostafa RonaghiSVPSell10,000$159.81$1,598,100.00View SEC Filing  
9/30/2014A Blaine BowmanDirectorSell5,000$164.02$820,100.00View SEC Filing  
9/29/2014Gerald MoellerDirectorSell5,000$164.89$824,450.00View SEC Filing  
9/25/2014Jay T FlatleyCEOSell25,000$164.43$4,110,750.00View SEC Filing  
9/24/2014Christian O HenrySVPSell20,000$167.28$3,345,600.00View SEC Filing  
9/23/2014A Blaine BowmanDirectorSell5,000$168.50$842,500.00View SEC Filing  
9/16/2014A Blaine BowmanDirectorSell5,000$169.60$848,000.00View SEC Filing  
9/15/2014Daniel BradburyDirectorSell2,100$168.57$353,997.00View SEC Filing  
9/15/2014Jay T FlatleyCEOSell25,000$176.06$4,401,500.00View SEC Filing  
9/15/2014Marc StapleyCFOSell1,422$169.05$240,389.10View SEC Filing  
9/15/2014Nicholas NaclerioSVPSell2,000$169.53$339,060.00View SEC Filing  
9/9/2014A Blaine BowmanDirectorSell5,000$178.08$890,400.00View SEC Filing  
9/3/2014Christian O HenrySVPSell10,000$180.59$1,805,900.00View SEC Filing  
9/3/2014Daniel BradburyDirectorSell2,100$179.77$377,517.00View SEC Filing  
9/2/2014A Blaine BowmanDirectorSell5,000$179.67$898,350.00View SEC Filing  
9/2/2014Michel BouchardVPSell686$180.07$123,528.02View SEC Filing  
9/2/2014Mostafa RonaghiSVPSell10,000$179.66$1,796,600.00View SEC Filing  
8/28/2014Jay T FlatleyCEOSell30,000$178.98$5,369,400.00View SEC Filing  
8/26/2014A Blaine BowmanDirectorSell5,000$179.22$896,100.00View SEC Filing  
8/22/2014Daniel BradburyDirectorSell2,100$172.24$361,704.00View SEC Filing  
8/19/2014A Blaine BowmanDirectorSell5,000$171.70$858,500.00View SEC Filing  
8/15/2014Nicholas NaclerioSVPSell2,000$167.23$334,460.00View SEC Filing  
8/15/2014Roy A WhitfieldDirectorSell4,000$169.28$677,120.00View SEC Filing  
8/13/2014Christian O HenrySVPSell20,000$164.66$3,293,200.00View SEC Filing  
8/5/2014A Blaine BowmanDirectorSell5,000$159.91$799,550.00View SEC Filing  
8/4/2014Daniel BradburyDirectorSell2,100$159.77$335,517.00View SEC Filing  
8/1/2014Mostafa RonaghiSVPSell10,000$159.73$1,597,300.00View SEC Filing  
7/29/2014A Blaine BowmanDirectorSell5,000$166.89$834,450.00View SEC Filing  
7/29/2014Christian O HenrySVPSell10,000$167.40$1,674,000.00View SEC Filing  
7/24/2014Jay T FlatleyCEOSell30,000$175.43$5,262,900.00View SEC Filing  
7/23/2014Daniel BradburyDirectorSell2,100$177.87$373,527.00View SEC Filing  
7/15/2014Nicholas NaclerioSVPSell2,000$174.26$348,520.00View SEC Filing  
7/14/2014Marc StapleyCFOSell1,422$177.59$252,532.98View SEC Filing  
7/10/2014Jay T FlatleyCEOSell30,000$172.56$5,176,800.00View SEC Filing  
7/8/2014Daniel BradburyDirectorSell2,100$172.89$363,069.00View SEC Filing  
7/1/2014Mostafa RonaghiSVPSell10,000$179.47$1,794,700.00View SEC Filing  
6/30/2014Gerald MoellerDirectorSell5,000$178.97$894,850.00View SEC Filing  
6/27/2014Daniel BradburyDirectorSell2,100$171.65$360,465.00View SEC Filing  
6/26/2014Jay T FlatleyCEOSell30,000$170.11$5,103,300.00View SEC Filing  
6/24/2014Christian O HenrySVPSell10,000$172.60$1,726,000.00View SEC Filing  
6/16/2014Christian O HenrySVPSell20,000$169.73$3,394,600.00View SEC Filing  
6/16/2014Marc StapleyCFOSell1,422$169.25$240,673.50View SEC Filing  
6/12/2014Daniel BradburyDirectorSell2,100$171.17$359,457.00View SEC Filing  
6/12/2014Jay T FlatleyCEOSell30,000$172.25$5,167,500.00View SEC Filing  
6/2/2014Karin EasthamDirectorSell6,000$157.56$945,360.00View SEC Filing  
6/2/2014Michel BouchardCAOSell1,491$155.51$231,865.41View SEC Filing  
6/2/2014Mostafa RonaghiSVPSell10,000$156.93$1,569,300.00View SEC Filing  
5/22/2014Jay FlatleyCEOSell30,000$154.95$4,648,500.00View SEC Filing  
5/15/2014Nicholas NaclerioSVPSell2,000$141.72$283,440.00View SEC Filing  
5/15/2014Roy WhitfieldDirectorSell4,000$143.71$574,840.00View SEC Filing  
5/14/2014Daniel BradburyDirectorSell2,100$146.46$307,566.00View SEC Filing  
5/14/2014Marc StapleyCFOSell1,422$146.94$208,948.68View SEC Filing  
5/8/2014Jay FlatleyCEOSell30,000$143.59$4,307,700.00View SEC Filing  
5/2/2014Daniel BradburyDirectorSell2,100$139.66$293,286.00View SEC Filing  
5/1/2014Mostafa RonaghiSVPSell10,000$135.91$1,359,100.00View SEC Filing  
4/24/2014Jay FlatleyCEOSell30,000$150.80$4,524,000.00View SEC Filing  
4/15/2014Daniel BradburyDirectorSell2,100$131.29$275,709.00View SEC Filing  
4/15/2014Nicholas NaclerioSVPSell2,000$133.56$267,120.00View SEC Filing  
4/14/2014Marc StapleyCFOSell1,422$134.80$191,685.60View SEC Filing  
4/10/2014Jay FlatleyCEOSell30,000$139.90$4,197,000.00View SEC Filing  
4/4/2014Daniel BradburyDirectorSell2,100$138.44$290,724.00View SEC Filing  
4/1/2014Mostafa RonaghiSVPSell10,000$152.41$1,524,100.00View SEC Filing  
3/27/2014Jay FlatleyCEOSell30,000$140.11$4,203,300.00View SEC Filing  
3/19/2014Daniel BradburyDirectorSell2,100$161.14$338,394.00View SEC Filing  
3/17/2014Gerald MoellerDirectorSell10,000$161.92$1,619,200.00View SEC Filing  
3/17/2014Nicholas NaclerioSVPSell2,000$163.65$327,300.00View SEC Filing  
3/14/2014Marc StapleyCFOSell1,422$163.35$232,283.70View SEC Filing  
3/13/2014Jay FlatleyCEOSell30,000$165.96$4,978,800.00View SEC Filing  
3/11/2014Christian HenrySVPSell3,000$167.16$501,480.00View SEC Filing  
3/11/2014Michel BouchardCAOSell2,168$167.21$362,511.28View SEC Filing  
3/3/2014Michel BouchardCAOSell2,994$176.81$529,369.14View SEC Filing  
2/25/2014Michel BouchardCAOSell24,505$176.13$4,316,065.65View SEC Filing  
2/24/2014Roy WhitfieldDirectorSell2,000$175.26$350,520.00View SEC Filing  
2/18/2014Nicholas NaclerioSVPSell2,000$169.77$339,540.00View SEC Filing  
2/13/2014Jay FlatleyCEOSell30,000$160.43$4,812,900.00View SEC Filing  
2/7/2014Jay FlatleyCEOSell5,000$152.23$761,150.00View SEC Filing  
1/31/2014Marc StapleyCFOSell20,038$151.32$3,032,150.16View SEC Filing  
1/23/2014Jay FlatleyCEOSell30,000$142.30$4,269,000.00View SEC Filing  
1/9/2014Jay FlatleyCEOSell30,000$114.77$3,443,100.00View SEC Filing  
12/26/2013Jay FlatleyCEOSell30,000$107.88$3,236,400.00View SEC Filing  
12/17/2013Gregory HeathSVPSell1,875$102.68$192,525.00View SEC Filing  
10/30/2013Christian O HenrySVPSell6,000$93.29$559,740.00View SEC Filing  
10/30/2013David R WaltDirectorSell5,000$93.02$465,100.00View SEC Filing  
10/28/2013William H RastetterDirectorSell20,000$92.37$1,847,400.00View SEC Filing  
10/24/2013Jay T FlatleyCEOSell30,000$92.32$2,769,600.00View SEC Filing  
10/22/2013Nicholas NaclerioSVPSell20,000$90.00$1,800,000.00View SEC Filing  
10/17/2013Gregory HeathSVPSell1,875$82.09$153,918.75View SEC Filing  
10/16/2013David R WaltDirectorSell5,000$82.59$412,950.00View SEC Filing  
10/15/2013Nicholas NaclerioSVPSell4,000$81.32$325,280.00View SEC Filing  
10/10/2013Christian HenrySVPSell6,000$77.73$466,380.00View SEC Filing  
10/10/2013Jay FlatleyCEOSell20,000$77.75$1,555,000.00View SEC Filing  
10/2/2013David R WaltDirectorSell5,000$80.58$402,900.00View SEC Filing  
9/18/2013David WaltDirectorSell5,000$83.11$415,550.00View SEC Filing  
9/17/2013Gregory HeathSVPSell1,875$85.20$159,750.00View SEC Filing  
9/16/2013Jay FlatleyCEOSell30,000$83.27$2,498,100.00View SEC Filing  
9/16/2013Nicholas NaclerioSVPSell4,000$85.00$340,000.00View SEC Filing  
9/10/2013Gregory HeathSVPSell1,875$82.00$153,750.00View SEC Filing  
9/9/2013Paul L BianchiSVPSell1,627$79.03$128,581.81View SEC Filing  
9/5/2013Christian O HenrySVPSell9,000$78.17$703,530.00View SEC Filing  
9/4/2013David R WaltDirectorSell5,000$77.18$385,900.00View SEC Filing  
9/3/2013Nicholas NaclerioSVPSell59,000$76.91$4,537,690.00View SEC Filing  
9/3/2013Roy A WhitfieldDirectorSell2,000$78.49$156,980.00View SEC Filing  
8/30/2013Mark LewisSVPSell5,000$78.12$390,600.00View SEC Filing  
8/22/2013Jay FlatleyCEOSell20,000$78.65$1,573,000.00View SEC Filing  
8/21/2013David WaltDirectorSell5,000$78.34$391,700.00View SEC Filing  
8/15/2013Nicholas NaclerioSVPSell2,000$78.43$156,860.00View SEC Filing  
8/8/2013Jay FlatleyCEOSell20,000$78.07$1,561,400.00View SEC Filing  
8/7/2013David WaltDirectorSell5,000$78.29$391,450.00View SEC Filing  
8/2/2013Michel BouchardVPSell11,465$80.64$924,537.60View SEC Filing  
7/25/2013Christian O HenrySVPSell11,462$80.89$927,161.18View SEC Filing  
7/25/2013Jay T FlatleyCEOSell20,000$81.01$1,620,200.00View SEC Filing  
7/24/2013David R WaltDirectorSell4,600$81.44$374,624.00View SEC Filing  
7/24/2013Gregory HeathSVPSell209,533$82.00$17,181,706.00View SEC Filing  
7/24/2013Michel BouchardVPSell9,789$79.28$776,071.92View SEC Filing  
7/15/2013Nicholas NaclerioSVPSell2,000$74.50$149,000.00View SEC Filing  
7/11/2013Jay T FlatleyCEOSell20,000$74.90$1,498,000.00View SEC Filing  
7/11/2013Mostafa RonaghiSVPSell24,000$74.95$1,798,800.00View SEC Filing  
7/10/2013David R WaltDirectorSell5,000$74.26$371,300.00View SEC Filing  
7/10/2013Michel BouchardVPSell3,618$74.30$268,817.40View SEC Filing  
7/9/2013Christian O HenrySVPSell9,000$74.01$666,090.00View SEC Filing  
6/27/2013Jay T FlatleyCEOSell20,000$74.96$1,499,200.00View SEC Filing  
6/26/2013David R WaltDirectorSell5,000$75.36$376,800.00View SEC Filing  
6/26/2013Michel BouchardVPSell4,272$75.06$320,656.32View SEC Filing  
6/25/2013Tristan OrpinSVPSell35,000$71.98$2,519,300.00View SEC Filing  
6/17/2013Nicholas NaclerioSVPSell2,000$68.56$137,120.00View SEC Filing  
6/14/2013Christian O HenrySVPSell25,959$68.10$1,767,807.90View SEC Filing  
6/13/2013Jay T FlatleyCEOSell20,000$66.49$1,329,800.00View SEC Filing  
6/13/2013Tristan OrpinSVPSell47,667$66.55$3,172,238.85View SEC Filing  
6/12/2013David R WaltDirectorSell5,000$67.67$338,350.00View SEC Filing  
6/12/2013Michel BouchardVPSell5,170$68.64$354,868.80View SEC Filing  
6/11/2013Mostafa RonaghiSVPSell24,000$69.01$1,656,240.00View SEC Filing  
6/3/2013Karin EasthamDirectorSell10,000$70.34$703,400.00View SEC Filing  
5/31/2013Mark L LewisSVPSell13,000$71.72$932,360.00View SEC Filing  
5/30/2013Matthew L PosardSVPSell2,836$70.80$200,788.80View SEC Filing  
5/29/2013David R WaltDirectorSell5,000$70.92$354,600.00View SEC Filing  
5/29/2013Michel BouchardVPSell6,276$71.02$445,721.52View SEC Filing  
5/21/2013Jay T FlatleyCEOSell24,000$69.39$1,665,360.00View SEC Filing  
5/20/2013Marc StapleyCFOSell2,843$73.38$208,619.34View SEC Filing  
5/15/2013David R WaltDirectorSell5,000$70.73$353,650.00View SEC Filing  
5/15/2013Michel BouchardVPSell14,241$70.71$1,006,981.11View SEC Filing  
5/15/2013Nicholas NaclerioSVPSell2,000$70.72$141,440.00View SEC Filing  
5/13/2013Mostafa RonaghiSVPSell24,000$68.83$1,651,920.00View SEC Filing  
5/10/2013Tristan OrpinSVPSell25,000$69.60$1,740,000.00View SEC Filing  
5/9/2013Jay T FlatleyCEOSell20,000$66.63$1,332,600.00View SEC Filing  
5/7/2013Tristan OrpinSVPSell5,000$65.68$328,400.00View SEC Filing  
4/8/2013Christian CabouSVPSell16,500$55.00$907,500.00View SEC Filing  
4/8/2013Marc StapleyCFOSell9,175$55.00$504,625.00View SEC Filing  
4/8/2013William H RastetterDirectorSell20,000$54.95$1,099,000.00View SEC Filing  
3/11/2013Marc StapleyCFOSell4,468$53.71$239,976.28View SEC Filing  
11/8/2012Jay T FlatleyCEOSell5,000$47.99$239,950.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Illumina (NASDAQ:ILMN)
DateHeadline
finance.yahoo.com logoIllumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina (NASDAQ:ILMN)
finance.yahoo.com - February 20 at 10:39 AM
News IconIllumina, Inc. (NASDAQ:ILMN) Daily Sentiment Score At 0.16 | Stock ... - Stock Observer (NASDAQ:ILMN)
www.thestockobserver.com - February 18 at 10:55 AM
News IconIllumina, Inc. (NASDAQ:ILMN) Long-Term Growth Estimate At $13.6 - Transcript Daily (NASDAQ:ILMN)
transcriptdaily.com - February 18 at 10:55 AM
fool.com logoWhy Illumina Is a Buy (NASDAQ:ILMN)
www.fool.com - February 18 at 10:55 AM
finance.yahoo.com logoILLUMINA INC Financials (NASDAQ:ILMN)
finance.yahoo.com - February 17 at 5:33 PM
News IconIllumina, Inc. (NASDAQ:ILMN) Quarterly EPS At $1.22 | Stock Observer - Stock Observer (NASDAQ:ILMN)
www.thestockobserver.com - February 15 at 9:02 PM
fool.com logo3 Stocks Set to Profit From the Rise of China (NASDAQ:ILMN)
www.fool.com - February 15 at 9:02 PM
biz.yahoo.com logoILLUMINA INC Files SEC form 10-K, Annual Report (NASDAQ:ILMN)
us.rd.yahoo.com - February 14 at 7:15 PM
fool.com logoWhat Illumina's New Products Mean for 2017 and Beyond (NASDAQ:ILMN)
www.fool.com - February 14 at 7:27 AM
globenewswire.com logoDEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Illumina, Inc. of Commencement of a Class ... - GlobeNewswire (press release) (NASDAQ:ILMN)
globenewswire.com - February 14 at 4:55 AM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses Exceeding $250,000 to Contact the Firm (NASDAQ:ILMN)
finance.yahoo.com - February 13 at 11:55 PM
finance.yahoo.com logoDEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Illumina, Inc. of Commencement of a … (NASDAQ:ILMN)
finance.yahoo.com - February 13 at 6:54 PM
us.rd.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses Exceeding $250,000 to Contact the Firm (NASDAQ:ILMN)
us.rd.yahoo.com - February 13 at 6:54 PM
us.rd.yahoo.com logoBaron Funds' Fifth Avenue Growth Fund Comments on Illumina (NASDAQ:ILMN)
us.rd.yahoo.com - February 13 at 6:54 PM
feeds.benzinga.com logoDEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Illumina, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 – ILMN (NASDAQ:ILMN)
feeds.benzinga.com - February 13 at 2:52 PM
fool.com logoBetter Buy: Illumina or Gilead Sciences? (NASDAQ:ILMN)
www.fool.com - February 13 at 2:30 PM
seekingalpha.com logoIllumina, Inc. (ILMN) (NASDAQ:ILMN)
seekingalpha.com - February 13 at 11:10 AM
biz.yahoo.com logoILLUMINA INC Files SEC form 8-K, Other Events (NASDAQ:ILMN)
us.rd.yahoo.com - February 13 at 11:10 AM
us.rd.yahoo.com logoDEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Illumina Inc. (ILMN) & Lead Plaintiff Deadline: February 14, 2017 (NASDAQ:ILMN)
us.rd.yahoo.com - February 13 at 11:10 AM
News IconIllumina, Inc. (NASDAQ:ILMN) Mean Price Target At $152.437 - Transcript Daily (NASDAQ:ILMN)
transcriptdaily.com - February 12 at 10:48 PM
News IconIllumina, Inc. (NASDAQ:ILMN) Bearish Target At $185 - Stock Observer (NASDAQ:ILMN)
www.thestockobserver.com - February 12 at 10:48 PM
businesswire.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Illumina, Inc. of Commencement of a Class Action ... - Business Wire (press release) (NASDAQ:ILMN)
www.businesswire.com - February 9 at 4:37 AM
News IconBetter Buy: Illumina, Inc. vs. Thermo Fisher Scientific - Fox Business (NASDAQ:ILMN)
www.foxbusiness.com - February 9 at 4:37 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Illumina, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 – ILMN (NASDAQ:ILMN)
finance.yahoo.com - February 8 at 6:35 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm (NASDAQ:ILMN)
finance.yahoo.com - February 8 at 6:35 PM
fool.com logoBetter Buy: Illumina, Inc. vs. Thermo Fisher Scientific (NASDAQ:ILMN)
www.fool.com - February 8 at 6:35 PM
prnewswire.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Illumina, Inc. - ILMN - PR Newswire (press release) (NASDAQ:ILMN)
www.prnewswire.com - February 8 at 12:14 AM
finance.yahoo.com logoDEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Illumina Inc. (ILMN) and Lead Plaintiff Deadline: February 14, 2017 (NASDAQ:ILMN)
finance.yahoo.com - February 7 at 7:11 PM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm (NASDAQ:ILMN)
finance.yahoo.com - February 7 at 7:11 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Illumina, Inc. - ILMN (NASDAQ:ILMN)
finance.yahoo.com - February 7 at 7:11 PM
fool.com logoWhy Illumina, Inc. Soared 25% in January - Motley Fool (NASDAQ:ILMN)
www.fool.com - February 6 at 10:57 PM
fool.com logoWhy Illumina, Inc. Soared 25% in January (NASDAQ:ILMN)
www.fool.com - February 6 at 4:31 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Illumina, Inc. to Contact the Firm Before Imminent Lead Plaintiff Deadline (NASDAQ:ILMN)
us.rd.yahoo.com - February 6 at 10:35 AM
nasdaq.com logoNotable ETF Inflow Detected - RSP, ILMN, NRG, CSX (NASDAQ:ILMN)
www.nasdaq.com - February 3 at 11:31 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc. of Class Action Lawsuit and Upcoming Deadline - ILMN (NASDAQ:ILMN)
us.rd.yahoo.com - February 3 at 11:31 PM
businesswire.com logoILMN SHAREHOLDER ALERT: The Law Offices of Vincent Wong ... - Business Wire (press release) (NASDAQ:ILMN)
www.businesswire.com - February 3 at 6:28 PM
finance.yahoo.com logoILMN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Illumina, Inc. and a Lead Plaintiff Deadline of February 14, 2017 (NASDAQ:ILMN)
finance.yahoo.com - February 3 at 6:28 PM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Illumina Inc. (ILMN) and Lead Plaintiff Deadline: February 14, 2017 (NASDAQ:ILMN)
finance.yahoo.com - February 3 at 6:28 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm (NASDAQ:ILMN)
finance.yahoo.com - February 3 at 6:28 PM
us.rd.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm (NASDAQ:ILMN)
us.rd.yahoo.com - February 2 at 11:34 PM
barrons.com logo[$$] Illumina, Up 26% So Far This Year, Can Stay Hot (NASDAQ:ILMN)
www.barrons.com - February 2 at 6:33 PM
capitalcube.com logoIllumina, Inc. :ILMN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 2, 2017 (NASDAQ:ILMN)
www.capitalcube.com - February 2 at 6:33 PM
capitalcube.com logoIllumina, Inc. :ILMN-US: Earnings Analysis: 2016 By the Numbers : February 2, 2017 (NASDAQ:ILMN)
www.capitalcube.com - February 2 at 6:33 PM
fool.com logoIllumina Inc. Ends 2016 on a Strong Note Thanks to Consumables Sales - Motley Fool (NASDAQ:ILMN)
www.fool.com - February 1 at 11:38 PM
investopedia.com logoIllumina Q4 Results Beat the Street (ILMN) (NASDAQ:ILMN)
www.investopedia.com - February 1 at 6:37 PM
us.rd.yahoo.com logoEdited Transcript of ILMN earnings conference call or presentation 31-Jan-17 10:00pm GMT (NASDAQ:ILMN)
us.rd.yahoo.com - February 1 at 6:37 PM
fool.com logo5 Growth Stocks to Buy in February (NASDAQ:ILMN)
us.rd.yahoo.com - February 1 at 6:37 PM
fool.com logoTop Healthcare Stocks to Buy in 2017 (NASDAQ:ILMN)
us.rd.yahoo.com - February 1 at 6:37 PM
us.rd.yahoo.com logoInvestor Alert: GPM Reminds Investors of the February 14 Deadline in the Class Action Lawsuit Against Illumina, Inc. (NASDAQ:ILMN)
us.rd.yahoo.com - February 1 at 6:37 PM
investopedia.com logoIllumina Q4 Results Beat the Street (NASDAQ:ILMN)
www.investopedia.com - February 1 at 6:37 PM

Social

What is Illumina's stock symbol?

Illumina trades on the NASDAQ under the ticker symbol "ILMN."

Where is Illumina's stock going? Where will Illumina's stock price be in 2017?

23 analysts have issued twelve-month price targets for Illumina's shares. Their forecasts range from $100.00 to $200.00. On average, they anticipate Illumina's share price to reach $150.80 in the next twelve months.

When will Illumina announce their earnings?

Illumina is scheduled to release their next quarterly earnings announcement on Monday, May, 1st 2017.

What are analysts saying about Illumina stock?

Here are some recent quotes from research analysts about Illumina stock:

  • According to Zacks Investment Research, "Illumina witnessed a robust share price movement as compared to the Zack Categorized Medical-Biomed/Genetics subindustry trend in the past six months. However a dismal estimate revision trend indicates looming concerns ahead. The company posted mixed third-quarter results with earnings surpassing the Zacks Consensus Estimate while revenues missed the mark as well as the company’s expectations. On a positive note, the company performed well in the Asia Pacific and Europe. There was also robust sequencing and array consumable growth in the third quarter. However narrow EPS guidance for the full year adds to woes.  Revenues in the Americas witnessed a slower pace of growth. Overall, the year-over-year fall in sequencing instrument revenue due to the challenging HiSeq X comparison marred the entire performance." (12/13/2016)

  • Cantor Fitzgerald analysts commented, "ILMN remains confident that weakness was due to internal execution and not PACB Sequel launch. Subsequent to the preannouncement, ILMN gained greater insight into the drivers behind the HiSeq weakness, including the timing of funding, assessing NextSeqs, and delays in deliveries (see exhibit 2). The company is confident that few, if any, of these are related to customers using funding to purchase PACB’s Sequel." (5/4/2016)

  • Morgan Stanley analysts commented, "We expected the slowing to emerge more slowly given the healthy growth we see in sequencing volumes in the research channel (Signs of Improvement in the Research Channel (06 Signs of Improvement in the Research Channel (06 Apr) Apr)) and indications of new user demand in our fall ’15 survey. We expect our upcoming spring ’16 sequencing survey to find weaker new user demand." (4/19/2016)

Who owns Illumina stock?

Illumina's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Baillie Gifford & Co. (12.78%), Edgewood Management LLC (4.52%), Sands Capital Management LLC (3.89%), FMR LLC (0.56%), Frontier Capital Management Co. LLC (0.33%) and TCW Group Inc. (0.28%). Company insiders that own Illumina stock include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, David R Walt, Gerald Moeller, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Nicholas Naclerio, Omead Ostadan, Paul L Bianchi, Richard Klausner, Robert S Epstein and Roy A Whitfield.

Who sold Illumina stock? Who is selling Illumina stock?

Illumina's stock was sold by a variety of institutional investors in the last quarter, including Sands Capital Management LLC, Credit Agricole S A, TCW Group Inc., Orbimed Advisors LLC, Capital Guardian Trust Co., FMR LLC, Marshall Wace LLP and Fiera Capital Corp. Company insiders that have sold Illumina stock in the last year include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, David R Walt, Jay T Flatley, Karin Eastham, Marc Stapley, Nicholas Naclerio, Omead Ostadan, Paul L Bianchi, Robert S Epstein and Roy A Whitfield.

Who bought Illumina stock? Who is buying Illumina stock?

Illumina's stock was purchased by a variety of institutional investors in the last quarter, including Edgewood Management LLC, Viking Global Investors LP, Asset Management One Co. Ltd., Janus Capital Management LLC, Baillie Gifford & Co., ARK Investment Management LLC, Everett Capital Advisors UK LLP and Russell Investments Group Ltd..

How do I buy Illumina stock?

Shares of Illumina can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Illumina stock cost?

One share of Illumina stock can currently be purchased for approximately $162.15.

Illumina (NASDAQ:ILMN) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Earnings History Chart

Earnings by Quarter for Illumina (NASDAQ:ILMN)

Dividend History Chart

Dividend Payments by Quarter for Illumina (NASDAQ:ILMN)

Last Updated on 2/22/2017 by MarketBeat.com Staff